1. Home
  2. CDNA vs CGBD Comparison

CDNA vs CGBD Comparison

Compare CDNA & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.44

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Carlyle Secured Lending Inc.

CGBD

Carlyle Secured Lending Inc.

HOLD

Current Price

$11.75

Market Cap

913.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
CGBD
Founded
1998
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
913.5M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
CDNA
CGBD
Price
$19.44
$11.75
Analyst Decision
Buy
Hold
Analyst Count
7
7
Target Price
$26.67
$13.70
AVG Volume (30 Days)
656.6K
521.0K
Earning Date
02-24-2026
02-24-2026
Dividend Yield
N/A
13.84%
EPS Growth
N/A
N/A
EPS
1.22
1.14
Revenue
$357,998,000.00
$245,008,000.00
Revenue This Year
$14.49
$12.93
Revenue Next Year
$11.32
$3.04
P/E Ratio
$16.16
$10.48
Revenue Growth
14.46
2.55
52 Week Low
$10.96
$11.55
52 Week High
$25.55
$18.40

Technical Indicators

Market Signals
Indicator
CDNA
CGBD
Relative Strength Index (RSI) 48.29 35.85
Support Level $18.81 $11.87
Resistance Level $21.00 $12.33
Average True Range (ATR) 1.11 0.29
MACD -0.13 -0.03
Stochastic Oscillator 40.03 14.27

Price Performance

Historical Comparison
CDNA
CGBD

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

Share on Social Networks: